Cargando…

Monotherapy in patients with type 2 diabetes mellitus

Mostrar otras versiones (1)

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhee, Sang Youl, Kim, Hyun Jin, Ko, Seung-Hyun, Hur, Kyu Yeon, Kim, Nan-Hee, Moon, Min Kyong, Park, Seok-O, Lee, Byung-Wan, Choi, Kyung Mook, Kim, Jin Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668404/ https://www.ncbi.nlm.nih.gov/pubmed/29057643 http://dx.doi.org/10.3904/kjim.2017.312

Ejemplares similares

Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017)

2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
por: Kim, Mee Kyoung, et al.
Publicado: (2019)

2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
por: Hur, Kyu Yeon, et al.
Publicado: (2021)

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2023)

2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
por: Choi, Jong Han, et al.
Publicado: (2023)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
por: Kim, Hae Jin, et al.
Publicado: (2022)

Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Oh, Tae Jung, et al.
Publicado: (2020)

Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2021)

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
por: Kim, Nam Hoon, et al.
Publicado: (2017)

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
por: Baek, Jong Ha, et al.
Publicado: (2022)

Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020
por: Ko, Seung-Hyun, et al.
Publicado: (2023)

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
por: Noh, Junghyun, et al.
Publicado: (2023)

The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus
por: Kim, Hae Jin, et al.
Publicado: (2019)

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
por: Park, In Hae, et al.
Publicado: (2019)

Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
por: Kim, Sin Gon, et al.
Publicado: (2014)

A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B
por: Lee, Kyung Jae, et al.
Publicado: (2018)

Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus
por: Park, So Young, et al.
Publicado: (2017)

Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013
por: Kim, Kyeong Jin, et al.
Publicado: (2018)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
por: Rhee, Moo-Yong, et al.
Publicado: (2015)

Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2015)

Identification of microRNAs and their target genes in the placenta as biomarkers of inflammation
por: Jang, Hee Yeon, et al.
Publicado: (2020)

PM402. Factors associated with sexual health in Korean patients with schizophrenia receiving risperidone monotherapy
por: Lee, Ju-Yeon, et al.
Publicado: (2016)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
por: Yoon, Kun Ho, et al.
Publicado: (2011)

Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
por: Lee, Seung-Eun, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study
por: Kim, Kyoung Jin, et al.
Publicado: (2021)

miR-373-3p Regulates Invasion and Migration Abilities of Trophoblast Cells via Targeted CD44 and Radixin
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
por: Yun, Soo Jin, et al.
Publicado: (2022)

Low Economic Status Is Identified as an Emerging Risk Factor for Diabetes Mellitus in Korean Men Aged 30 to 59 Years in Korean National Health and Nutrition Examination Survey 2008 to 2010
por: Koo, Bo Kyung, et al.
Publicado: (2015)

A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Yang, Sae Jeong, et al.
Publicado: (2021)

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
por: Ko, Yoon Ho, et al.
Publicado: (2007)

Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
por: Kim, Jin Hwa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1u5eambt07dl9e3bfk43iq9djc